The FLUOX-PMS trial: Underestimating the challenge in progressive multiple sclerosis trials

Jeremy Chataway, Christopher J Weir, Robert J Fox

Research output: Contribution to journal › Editorial

Access to Document

AAM - The FLUOX-PMS trial...
This is the author’s peer-reviewed manuscript as accepted for publication.
Accepted author manuscript, 46.3 KB

@article{013c62ef14df4ce69548301909f79c2d,

title = "The FLUOX-PMS trial: Underestimating the challenge in progressive multiple sclerosis trials",

author = "Jeremy Chataway and Weir, {Christopher J} and Fox, {Robert J}",

year = "2019",

month = jun,

day = "20",

doi = "10.1177/1352458519856985",

language = "English",

pages = "1352458519856985",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications",

}

TY - JOUR

T1 - The FLUOX-PMS trial

T2 - Underestimating the challenge in progressive multiple sclerosis trials

AU - Chataway, Jeremy

AU - Weir, Christopher J

AU - Fox, Robert J

PY - 2019/6/20

Y1 - 2019/6/20

U2 - 10.1177/1352458519856985

DO - 10.1177/1352458519856985

M3 - Editorial

C2 - 31218918

SN - 1352-4585

SP - 1352458519856985

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

ER -